Phospho-Tpl2 (Ser400) AntibodyProduct information
|100 µl (10 western blots)||-||Unavailable in your region|
Product Pathways - MAPK Signaling
Phospho-Tpl2 (Ser400) Antibody #4491
|4491S||100 µl (10 western blots)||---||In Stock||---|
|4491||carrier free and custom formulation / quantity||email request|
|W||1:1000||Rat||Transfected Only||60, 62||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Species predicted to react based on 100% sequence homology: Human, Mouse.
Specificity / Sensitivity
Phospho-Tpl2 (Ser400) Antibody detects transfected Tpl2 only when phosphorylated at Ser400. This antibody does not cross-react with other phosphorylated MAP kinase kinase kinases.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a mixture synthetic phosphorylated peptides corresponding to residues surrounding Ser400 of human, mouse and rat Tpl2. Antibodies are purified by protein A and peptide affinity chromatography.
Western blot analysis of extracts from COS cells, untransfected or transfected with rat Tpl2 , using Phospho-Tpl2 (Ser400) Antibody (upper) and Tpl2 Antibody #4492 (lower). In lane 3, Tpl2 transfected COS cell lysate was treated with λ phosphatase to demonstrate the phospho-specificity of Phospho-Tpl2 (Ser400) Antibody.
Tpl2 (tumor progression locus 2), also known as COT (cancer osaka thyroid), is a serine/threonine kinase expressed primarily in hematopoietic tissues, lung and liver (1). Over-expression of Tpl2 potentiates MAP kinase pathways through MEK1 and SEK1, as well as through MKK6 and MEK5 (2,3). Tpl2 is also engaged in NF-κB activation through NF-κB inducing kinase (NIK), or by inducing phosphorylation and degradation of the NF-κB precusor, p105 NF-κB1 (4,5). Ser400 of Tpl2 is phosphorylated in an Akt-dependent manner. This phosphorylation is required for Tpl2-induced NF-κB-dependent transcription (6). Tpl2 also activates caspase-3 by promoting the assembly of a protein complex of Apaf1 (apoptotic protease-activating factor 1), caspase-9, Tpl2, adaptor protein Tvl1 and procaspase-3 (7).
- Patriotis, C. et al. (1993) Proc Natl Acad Sci U S A 90, 2251-5.
- Salmeron, A. et al. (1996) EMBO J 15, 817-26.
- Chiariello, M. et al. (2000) Mol Cell Biol 20, 1747-58.
- Lin, X. et al. (1999) Immunity 10, 271-80.
- Belich, M.P. et al. (1999) Nature 397, 363-8.
- Kane, L.P. et al. (2002) Mol Cell Biol 22, 5962-74.
- Patriotis, C. et al. (2001) J Cell Physiol 187, 176-87.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.